For immediate release.
10 September 2004
Not for release, publication or distribution in whole or in part in or into the
United States, Canada, Australia or Japan.
Recommended Offer
by UBS Investment Bank
on behalf of
Microgen plc
for AFA Systems plc
Microgen plc
Result of Extraordinary General Meeting
Microgen plc ('Microgen') announces that, at the Extraordinary General Meeting
of its shareholders held earlier today, all of the resolutions proposed,
including those to approve the Offer for AFA Systems plc, were duly passed.
The expressions in this announcement, unless the context otherwise requires,
bear the same meaning as in the Listing Particulars dated 18 August 2004.
Enquiries:
Microgen Tel: +44 (0)1753 847 122
Mike Phillips (Group Finance Director)
UBS Investment Bank, which is regulated in the United Kingdom by the Financial
Services Authority, is acting exclusively for Microgen and no one else in
connection with the Offer and will not be responsible to any person other than
Microgen for providing the protections afforded to its customers or for
providing advice in relation to the Offer.
END
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.